ATS 2018 International Conference - Mobile

Impact of Non-Alcoholic Fatty Liver Disease on Late Cardiovascular Events and Death in Chronic Obstructive Pulmonary Disease [Board No. P459]

Location: Board no. P459

Session Type: Thematic Poster Session

Sunday

May

20

11:15 AM

1:00 PM

Speaker(s)/Author(s)

Marie Joyeux-Faure

Pharm D, PhD
ADTSAS;Laboratoire EFCR et Sommeil

Renaud Tamisier

MD, PhD
HP2 Lab, Grenoble Alpes University;Laboratoire EFCR et Sommeil

Meriem Benmerad

Biostatistician
ADTSAS;Laboratoire EFCR et Sommeil

Maxime Maignan

MD, PhD
CHU Grenoble-Alpes

Anaïs Plazanet

MSc
CHU Grenoble-Alpes

Vincent Leroy

PhD
CHU Grenoble-Alpes

Ingrid Jullian-Desayes

Pharm D, PhD
ADTSAS;Laboratoire EFCR et Sommeil

Jean-Louis Pepin

MD, PhD
ADTSAS;CHU DE GRENOBLE;Laboratoire EFCR et Sommeil;University Grenoble Alpes;University Grenoble Alps

Jean-Pierre Zarski

PhD
CHU Grenoble-Alpes

Sébastien Bailly

Biostatistician, Pharm D, Ph, D
ADTSAS;Laboratoire EFCR et Sommeil

Damien Viglino

MD, MsC
CHU Grenoble-Alpes

View Abstract

Impact of Non-Alcoholic Fatty Liver Disease on Late Cardiovascular Events and Death in Chronic Obstructive Pulmonary Disease

Parent Sessions

A75 - COPD: TARGETS, MODELS, AND CLINICAL STUDIES...
05-20-2018 9:15 AM - 4:15 PM